Protokinetix, Inc. is a research and development stage biotechnology company engaged in the scientific medical research of anti-aging glycoproteins. The company is headquartered in Dalton, Ohio. The company went IPO on 2002-01-07. Company is focused on scientific medical research of Anti-Freeze Glycoproteins (AFGPs) or anti-aging glycoproteins. The Company’s anti-aging glycopeptide is for ophthalmology, dermatology, transplant support and biomanufacturing. The commercial applications for AAGPs include various health care solutions. The firm has not developed a commercially viable product and has not generated any revenue.
PKTX stock price ended at $0.01 on 水曜日, after rising 0.00%
On the latest trading day Jan 28, 2026, the stock price of PKTX rose by 0.00%, climbing from $0.01 to $0.01. Throughout the session, the stock experienced a volatility of 0.00%, with prices fluctuating between a daily low of $0.01 and a high of $0.01. Alongside this price increase, trading volume also rose by 585.8K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 179.0K shares were traded, amounting to a market value of approximately $3.9M.